We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

49 hedge funds and large institutions have $9.37M invested in Fortress Biotech in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 49 → 49 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

0.08% less ownership

Funds ownership: 0.71% → 0.63% (-0.08%)

21% less capital invested

Capital invested by funds: $11.9M → $9.37M (-$2.52M)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
12
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.44M
2
Millennium Management
Millennium Management
New York
+$1.24M
3
PP
Paloma Partners
Connecticut
+$281K
4
FIA
FNY Investment Advisers
New York
+$231K
5
Jane Street
Jane Street
New York
+$226K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.44M
2
State Street
State Street
Massachusetts
-$823K
3
SO
STRS Ohio
Ohio
-$476K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$243K
5
Charles Schwab
Charles Schwab
California
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Candriam SCA
Luxembourg
$34K +$38.6K +1,500 New
Goldman Sachs
27
Goldman Sachs
New York
$32K +$13.4K +523 +57%
DY
28
Dowling & Yahnke
California
$30K – – –
Renaissance Technologies
29
Renaissance Technologies
New York
$25K +$28.3K +1,102 New
DAS
30
Dynamic Advisor Solutions
Arizona
$21K +$24.5K +953 New
Citadel Advisors
31
Citadel Advisors
Florida
$20K +$23.1K +898 New
SIM
32
Spark Investment Management
New York
$19K +$22.2K +863 New
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$17K +$19.4K +756 New
LP
34
LMR Partners
United Kingdom
$17K +$19.8K +771 New
Deutsche Bank
35
Deutsche Bank
Germany
$13K -$63.2K -2,459 -80%
Citigroup
36
Citigroup
New York
$12K -$9.13K -355 -39%
EWM
37
Edge Wealth Management
New York
$9K +$10.3K +400 New
Legal & General Group
38
Legal & General Group
United Kingdom
$7K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$6.97K -$6.02K -234 -43%
CG
40
Cutler Group
California
$6K – – –
Barclays
41
Barclays
United Kingdom
$4K -$13.1K -508 -74%
Wells Fargo
42
Wells Fargo
California
$3K -$30.8K -1,197 -91%
UBS Group
43
UBS Group
Switzerland
$3K +$823 +32 +48%
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$2K – – –
MAM
45
Meeder Asset Management
Ohio
$2K – – –
Northwestern Mutual Wealth Management
46
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
APA
47
American Portfolios Advisors
New York
$675 – – –
SO
48
STRS Ohio
Ohio
– -$476K -18,500 Closed
Charles Schwab
49
Charles Schwab
California
– -$135K -5,044 Closed
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
– -$93K -3,474 Closed
1
2
3

FBIO Hedge Fund Activity: Q2 2019 in Review

49 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2019, worth a combined $9.37M — down 21% from $11.9M a quarter earlier.

Fund positioning in FBIO was balanced in Q2 2019: 15 funds opened new positions, 15 closed out, 7 added to existing stakes and 12 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.44M. The largest seller was BlackRock, cutting an estimated $2.44M.

  • 49 institutional investors held Fortress Biotech (FBIO) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $9.37M of Fortress Biotech stock for Q2 2019, down 21% quarter-over-quarter.
  • 15 funds opened new Fortress Biotech positions in Q2 2019 and 15 closed out, a net change of 0 holders.
  • The largest Fortress Biotech buyer in Q2 2019 was Vanguard Group, an estimated $1.44M added.
  • The largest Fortress Biotech seller in Q2 2019 was BlackRock, an estimated $2.44M sold.

Based on aggregated 13F filings for Q2 2019.